IFNA1 and neoplasm: While many tumours harbour mutations in key IFN genes or epigenetically silence them, the activation of oncogenic pathways or loss of tumour suppressors such as EGFR, Wnt B catenin, or Pten, all have links to IFN production or responsiveness [39,40].